UBS Maintains Buy on Omega Healthcare Invts, Raises Price Target to $56
Benzinga Newsdesk 4 hours ago
Analyst RatingsNewsPrice Target
UBS analyst Michael Goldsmith maintains Omega Healthcare Invts (NYSE:OHI) with a Buy and raises the price target from $52 to $56.
UBS analyst Michael Goldsmith maintains Omega Healthcare Invts (NYSE:OHI) with a Buy and raises the price target from $52 to $56.